Merck sues U.S. government over plan to negotiate Medicare drug prices, claiming "extortion"
CBSN
Drugmaker Merck is suing the U.S. government over its plan to allow Medicare to negotiate prices for a handful of drugs, calling it "extortion."
The plan, part of the 2022 Inflation Reduction Act, is expected to save taxpayers billions of dollars on common drugs the government pays for. The law directs the Center for Medicare and Medicaid Services to select 10 drugs with no generic or biosimilar equivalents to be subject to government price negotiation. (The list will eventually expand to 20 drugs.)
In its lawsuit, filed on Tuesday in federal court in the District of Columbia, Merck called the program "a sham" that "involves neither genuine 'negotiations' nor real 'agreements.'" Instead, the pharmaceutical firm said the U.S. Department of Health and Human Services selects drugs to be included and then dictates a discount, threatening drugmakers with "a ruinous daily excise tax" if they refuse the conditions.
BISBEE, Ariz. — Boots dusty, lungs heaving, Dr. John Wiens searched the boulders of a desolate Arizona mountaintop for the last survivors of a 3-million-year-old lizard population — then said the words that both confirmed his life's work and broke his heart. The California condor, the largest flying bird in the U.S., with about 90 adults remaining in the wild. The iconic Florida panther, with about 200 animals remaining. The massive North Atlantic right whale, which roams the Atlantic Ocean; all that's left are 250 individuals.
Americans are losing millions of dollars every year to criminals who steal money from their bank accounts through fraudulent wire transfers. Some U.S. senators are now pressing major banks for answers about what they are doing to stop the scammers. "Consumers should always be suspicious of people asking them for passcodes, access to their device, or money to prevent fraud. Banks won't make these requests or ask that you send money to yourself, but scammers will." – Chase spokesperson